甲磺酸那莫他酯溶液与透析液混合沉淀形成机理的探讨。

IF 1.1 4区 医学 Q4 ENGINEERING, BIOMEDICAL
Iori Okamoto, Koichiro Oji, Otoka Nakashima, Yoka Shu, Hisatsugu Takahara, Hitoshi Suzuki, Hitoshi Muguruma
{"title":"甲磺酸那莫他酯溶液与透析液混合沉淀形成机理的探讨。","authors":"Iori Okamoto, Koichiro Oji, Otoka Nakashima, Yoka Shu, Hisatsugu Takahara, Hitoshi Suzuki, Hitoshi Muguruma","doi":"10.1007/s10047-025-01500-3","DOIUrl":null,"url":null,"abstract":"<p><p>This study clarifies the reagent preparation and administration conditions that lead to precipitation when nafamostat mesylate salt (NM) solution is mixed with dialysate. The objective is to elucidate the mechanism of precipitation. It was observed that the Carbostar<sup>®</sup> dialysate forms a precipitate immediately after mixing with the NM solution, whereas Kindaly<sup>®</sup> and Subpac<sup>®</sup> dialysates form a precipitate after approximately 30 min. This variance is attributed to the pH adjusters used: citric acid for Carbostar<sup>®</sup>, acetic acid for Kindaly<sup>®</sup>, and hydrochloric acid for Subpac<sup>®</sup>. As trivalent negative ions, citrate ions promote faster precipitation compared to acetic acid and hydrochloric acid, which are monovalent ions. Nafamostat acetate and nafamostat chloride salts are soluble, while nafamostat citrate is poorly soluble, leading to differences in precipitation timing. The bicarbonate ion's pK<sub>a</sub> value is 6.1, meaning precipitation does not occur if the pH is lowered below 6.1 using acetic acid or hydrogen chloride as pH adjusters. The solubility product of nafamostat bicarbonate is 8.1 × 10<sup>-7</sup> (mol/L)<sup>3</sup>, making precipitation inevitable under dialysis conditions ([nafamostat<sup>2+</sup>] = 5 mg/mL (9.2 mM), [HCO<sub>3</sub><sup>-</sup>] = 35 mM). The primary precipitate component is nafamostat bicarbonate salt. Although NM is initially water-soluble, it undergoes chemical transformation into a poorly soluble salt through ion exchange from mesylate ions to bicarbonate ions within the dialysate, resulting in precipitation. Based on these findings, we propose conditions to avoid precipitation.</p>","PeriodicalId":15177,"journal":{"name":"Journal of Artificial Organs","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Elucidation of the mechanism of precipitate formation on mixing nafamostat mesylate solution with dialysate.\",\"authors\":\"Iori Okamoto, Koichiro Oji, Otoka Nakashima, Yoka Shu, Hisatsugu Takahara, Hitoshi Suzuki, Hitoshi Muguruma\",\"doi\":\"10.1007/s10047-025-01500-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This study clarifies the reagent preparation and administration conditions that lead to precipitation when nafamostat mesylate salt (NM) solution is mixed with dialysate. The objective is to elucidate the mechanism of precipitation. It was observed that the Carbostar<sup>®</sup> dialysate forms a precipitate immediately after mixing with the NM solution, whereas Kindaly<sup>®</sup> and Subpac<sup>®</sup> dialysates form a precipitate after approximately 30 min. This variance is attributed to the pH adjusters used: citric acid for Carbostar<sup>®</sup>, acetic acid for Kindaly<sup>®</sup>, and hydrochloric acid for Subpac<sup>®</sup>. As trivalent negative ions, citrate ions promote faster precipitation compared to acetic acid and hydrochloric acid, which are monovalent ions. Nafamostat acetate and nafamostat chloride salts are soluble, while nafamostat citrate is poorly soluble, leading to differences in precipitation timing. The bicarbonate ion's pK<sub>a</sub> value is 6.1, meaning precipitation does not occur if the pH is lowered below 6.1 using acetic acid or hydrogen chloride as pH adjusters. The solubility product of nafamostat bicarbonate is 8.1 × 10<sup>-7</sup> (mol/L)<sup>3</sup>, making precipitation inevitable under dialysis conditions ([nafamostat<sup>2+</sup>] = 5 mg/mL (9.2 mM), [HCO<sub>3</sub><sup>-</sup>] = 35 mM). The primary precipitate component is nafamostat bicarbonate salt. Although NM is initially water-soluble, it undergoes chemical transformation into a poorly soluble salt through ion exchange from mesylate ions to bicarbonate ions within the dialysate, resulting in precipitation. Based on these findings, we propose conditions to avoid precipitation.</p>\",\"PeriodicalId\":15177,\"journal\":{\"name\":\"Journal of Artificial Organs\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2025-04-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Artificial Organs\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1007/s10047-025-01500-3\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Artificial Organs","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s10047-025-01500-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

摘要

本研究阐明了甲磺酸那莫他盐(NM)溶液与透析液混合时产生沉淀的试剂制备及给药条件。目的是阐明降水的机制。观察到Carbostar®透析液在与NM溶液混合后立即形成沉淀,而Kindaly®和Subpac®透析液在大约30分钟后形成沉淀。这种差异归因于所使用的pH调节剂:Carbostar®为柠檬酸,Kindaly®为乙酸,Subpac®为盐酸。柠檬酸盐离子作为三价负离子,与一价离子乙酸和盐酸相比,促进了更快的沉淀。醋酸那莫司他盐和氯那莫司他盐是可溶的,而柠檬酸那莫司他盐是难溶的,导致沉淀时间的差异。碳酸氢盐离子的pKa值为6.1,这意味着如果使用醋酸或氯化氢作为pH调节剂将pH降低到6.1以下,则不会发生沉淀。碳酸氢钠那莫他酯的溶解度积为8.1 × 10-7 (mol/L)3,在透析条件下([nafamostat2+] = 5 mg/mL (9.2 mM), [HCO3-] = 35 mM)不可避免地产生沉淀。主要沉淀物成分为纳莫司他碳酸氢盐。虽然NM最初是水溶性的,但它在透析液中通过甲磺酸盐离子与碳酸氢盐离子的离子交换,发生化学转化为难溶盐,从而产生沉淀。基于这些发现,我们提出了避免降水的条件。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Elucidation of the mechanism of precipitate formation on mixing nafamostat mesylate solution with dialysate.

This study clarifies the reagent preparation and administration conditions that lead to precipitation when nafamostat mesylate salt (NM) solution is mixed with dialysate. The objective is to elucidate the mechanism of precipitation. It was observed that the Carbostar® dialysate forms a precipitate immediately after mixing with the NM solution, whereas Kindaly® and Subpac® dialysates form a precipitate after approximately 30 min. This variance is attributed to the pH adjusters used: citric acid for Carbostar®, acetic acid for Kindaly®, and hydrochloric acid for Subpac®. As trivalent negative ions, citrate ions promote faster precipitation compared to acetic acid and hydrochloric acid, which are monovalent ions. Nafamostat acetate and nafamostat chloride salts are soluble, while nafamostat citrate is poorly soluble, leading to differences in precipitation timing. The bicarbonate ion's pKa value is 6.1, meaning precipitation does not occur if the pH is lowered below 6.1 using acetic acid or hydrogen chloride as pH adjusters. The solubility product of nafamostat bicarbonate is 8.1 × 10-7 (mol/L)3, making precipitation inevitable under dialysis conditions ([nafamostat2+] = 5 mg/mL (9.2 mM), [HCO3-] = 35 mM). The primary precipitate component is nafamostat bicarbonate salt. Although NM is initially water-soluble, it undergoes chemical transformation into a poorly soluble salt through ion exchange from mesylate ions to bicarbonate ions within the dialysate, resulting in precipitation. Based on these findings, we propose conditions to avoid precipitation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Artificial Organs
Journal of Artificial Organs 医学-工程:生物医学
CiteScore
2.80
自引率
15.40%
发文量
68
审稿时长
6-12 weeks
期刊介绍: The aim of the Journal of Artificial Organs is to introduce to colleagues worldwide a broad spectrum of important new achievements in the field of artificial organs, ranging from fundamental research to clinical applications. The scope of the Journal of Artificial Organs encompasses but is not restricted to blood purification, cardiovascular intervention, biomaterials, and artificial metabolic organs. Additionally, the journal will cover technical and industrial innovations. Membership in the Japanese Society for Artificial Organs is not a prerequisite for submission.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信